Global Viral Inactivation Market
Sheridan, Sheridan/WY, 82801
The global viral inactivation
market was valued at USD 320.5 Million in 2016 and poised to grow
at a CAGR of 12.3% between 2016 and 2021, to reach USD 573.0 Million in 2021.
Viral inactivation testing is necessary by regulatory authorities for
investigational new drug (IND) submission and is mainly critical in process
development for biologicals including tissue and tissue products, stem cell
products, cellular and gene therapy products, blood and blood products, and
vaccine and therapeutics.
5 out of 5 from 1 reviews